BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14707512)

  • 1. A neurological symptom survey of patients with type I Gaucher disease.
    Pastores GM; Barnett NL; Bathan P; Kolodny EH
    J Inherit Metab Dis; 2003; 26(7):641-5. PubMed ID: 14707512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Non-neuronopathic' Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature.
    Biegstraaten M; van Schaik IN; Aerts JM; Hollak CE
    J Inherit Metab Dis; 2008 Jun; 31(3):337-49. PubMed ID: 18404411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological manifestations in patients with Gaucher disease and their relatives, it is just a coincidence?
    Giraldo P; Capablo JL; Alfonso P; Garcia-Rodriguez B; Latre P; Irun P; de Cabezon AS; Pocovi M
    J Inherit Metab Dis; 2011 Jun; 34(3):781-7. PubMed ID: 21384230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are symptoms of peripheral neuropathy more prevalent in patients with Gaucher disease?
    Halperin A; Elstein D; Zimran A
    Acta Neurol Scand; 2007 Apr; 115(4):275-8. PubMed ID: 17376127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG).
    Chérin P; Rose C; de Roux-Serratrice C; Tardy D; Dobbelaere D; Grosbois B; Hachulla E; Jaussaud R; Javier RM; Noël E; Clerson P; Hartmann A
    J Inherit Metab Dis; 2010 Aug; 33(4):331-8. PubMed ID: 20532983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gaucher disease: an overview of clinical characteristics and therapy.
    Kingma W
    J Intraven Nurs; 1996; 19(2):79-82. PubMed ID: 8852167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease.
    Biegstraaten M; Cox TM; Belmatoug N; Berger MG; Collin-Histed T; Vom Dahl S; Di Rocco M; Fraga C; Giona F; Giraldo P; Hasanhodzic M; Hughes DA; Iversen PO; Kiewiet AI; Lukina E; Machaczka M; Marinakis T; Mengel E; Pastores GM; Plöckinger U; Rosenbaum H; Serratrice C; Symeonidis A; Szer J; Timmerman J; Tylki-Szymańska A; Weisz Hubshman M; Zafeiriou DI; Zimran A; Hollak CEM
    Blood Cells Mol Dis; 2018 Feb; 68():203-208. PubMed ID: 28274788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.
    Stirnemann J; Belmatoug N; Camou F; Serratrice C; Froissart R; Caillaud C; Levade T; Astudillo L; Serratrice J; Brassier A; Rose C; Billette de Villemeur T; Berger MG
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A rare etiology of spinal cord compression: Gaucher disease].
    Neau D; Mercier P; Bouabdallah K; Vital JM; Fialon P; Longy-Boursier M; Le Bras M
    Rev Med Interne; 1993 Apr; 14(4):260-2. PubMed ID: 8378659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of Parkinson's syndrome in type I Gaucher disease.
    Neudorfer O; Giladi N; Elstein D; Abrahamov A; Turezkite T; Aghai E; Reches A; Bembi B; Zimran A
    QJM; 1996 Sep; 89(9):691-4. PubMed ID: 8917744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
    Khan A; Hangartner T; Weinreb NJ; Taylor JS; Mistry PK
    J Bone Miner Res; 2012 Aug; 27(8):1839-48. PubMed ID: 22692814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of Gaucher disease and its treatment on quality of life.
    Hayes RP; Grinzaid KA; Duffey EB; Elsas LJ
    Qual Life Res; 1998 Aug; 7(6):521-34. PubMed ID: 9737142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurological manifestations in patients with Gaucher disease and in their relatives].
    Giraldo P; Capablo JL; Alfonso P; Latre P; García B; Pocoví M;
    Med Clin (Barc); 2008 Jul; 131(5):175-9. PubMed ID: 18674488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of neurogenetics in Gaucher disease.
    Brady RO; Barton NW; Grabowski GA
    Arch Neurol; 1993 Nov; 50(11):1212-24. PubMed ID: 8215980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological evaluation of patients with Gaucher disease diagnosed as type 1.
    Capablo JL; Saenz de Cabezón A; Fraile J; Alfonso P; Pocovi M; Giraldo P;
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):219-22. PubMed ID: 17682016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study.
    Biegstraaten M; Mengel E; Maródi L; Petakov M; Niederau C; Giraldo P; Hughes D; Mrsic M; Mehta A; Hollak CE; van Schaik IN
    Brain; 2010 Oct; 133(10):2909-19. PubMed ID: 20693542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased incidence of Parkinson disease among relatives of patients with Gaucher disease.
    Halperin A; Elstein D; Zimran A
    Blood Cells Mol Dis; 2006; 36(3):426-8. PubMed ID: 16651014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complications of Gaucher's disease].
    Modrego Pardo PJ; Garzarán G; González N; Baiges JJ; Gazulla J
    Rev Clin Esp; 1992 Oct; 191(6):311-3. PubMed ID: 1470721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholelithiasis in patients with Gaucher disease.
    Rosenbaum H; Sidransky E
    Blood Cells Mol Dis; 2002; 28(1):21-7. PubMed ID: 11987238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report of the Spanish Gaucher's disease registry: clinical and genetic characteristics.
    Giraldo P; Pocoví M; Pérez-Calvo J; Rubio-Félix D; Giralt M
    Haematologica; 2000 Aug; 85(8):792-9. PubMed ID: 10942924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.